---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-113548"
form_type: "8-K"
ticker: "TRAW"
cik: "0001130598"
company_name: "Traws Pharma, Inc."
filed_at: "2024-11-01T23:59:59+00:00"
generated_at: "2026-05-30T06:49:17.084737+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Traws Pharma regains bid price compliance but remains at risk of delisting due to equity deficit

## Summary
- Regained compliance with Nasdaq minimum bid price requirement as of Oct 29, 2024 after 10 consecutive business days above $1.00.
- Company does not believe it satisfies Nasdaq stockholders' equity minimum of $2.5M; reported deficit of ~$(105.5)M as of June 30, 2024.
- Will present a plan to regain equity compliance at a Nasdaq hearing scheduled for November 14, 2024.

## SEC filing metadata
- accession: 0001104659-24-113548
- form_type: 8-K
- ticker: TRAW
- cik: 0001130598
- company_name: Traws Pharma, Inc.
- filed_at: 2024-11-01T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1130598/000110465924113548/0001104659-24-113548-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1130598/000110465924113548/tm2427326d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-113548
- JSON: https://secwatch.observer/filing/0001104659-24-113548.json
- Plain text: https://secwatch.observer/filing/0001104659-24-113548.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.